BOSTON SCIENTIFIC, EXECS INVEST $23 MILLION IN FIRM

Boston Scientific and a group of private investors have agreed to buy nearly 4.7 million shares of stock of an Atlanta, Ga., biopharmaceutical company. The stock purchase of Corautus Genetics totals about $18 million, and Boston Scientific amended its loan agreement with Corautus to make $5 million in loan proceeds immediately available. Corautus will raise a total of $23 million through the stock sale and amended loan agreement.

Boston Business Journal (http://boston.bizjournals.com/boston/stories/2005/06/27/daily33.html)